DOI: 10.2337/db08-0250 © 2008 by the American Diabetes Association
Response to Comment on: DiChiara et al. (2007) The Effect of Aspirin Dosing on Platelet Function in Diabetic and Nondiabetic Patients: An Analysis From the Aspirin-Induced Platelet Effect (ASPECT) Study: Diabetes 56:3014–3019, 2007From the Sinai Center for Thrombosis Research, Baltimore, Maryland Corresponding author: Paul A. Gurbel, MD, Sinai Center for Thrombosis Research, Hoffberger Building, Suite 56, 2401 W. Belvedere Ave., Baltimore, MD 21215. E-mail: pgurbel{at}lifebridgehealth.org We appreciate the concern of Dr. Klein in her reading (1) of our two articles. The demographic and laboratory data in the ASPECT article in Circulation are correct. The demographics presented in Table 1 in the Diabetes article (2) came from our first analysis of 100 patients from the ASPECT study (n = 30 diabetic subjects and 70 nondiabetic subjects). Please note that the percentages equal the n for every demographic variable indicating the n = 100 for the total group. The indicated percentages were from an initial analysis and inserted incorrectly in the Diabetes article. We had presented Table 1 at a prior conference and it was mistakenly included in the final draft of the submitted Diabetes manuscript.
Table 1 of this letter represents the analysis of the demographic data from the total 120 patients in whom platelet function was analyzed with respect to diabetes status in the Diabetes article. The analyses of the platelet function data that are presented in the Diabetes article are correct. We sincerely apologize for our error.
Received for publication February 20, 2008 and accepted in revised form February 20, 2008
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||